Microbot Medical Valuation
| CY9D Stock | 0.91 0.02 2.15% |
Today, the firm appears to be overvalued. Microbot Medical secures a last-minute Real Value of USD0.74 per share. The latest price of the firm is USD0.91. Our model forecasts the value of Microbot Medical from analyzing the firm fundamentals such as Current Valuation of 25.72 M, ebitda of (11.28 M), and Total Asset of 16.77 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Microbot Medical's price fluctuation is dangerous at this time. Calculation of the real value of Microbot Medical is based on 3 months time horizon. Increasing Microbot Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Microbot Medical's intrinsic value may or may not be the same as its current market price of 0.91, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.91 | Real 0.74 | Hype 0.91 | Naive 0.98 |
The intrinsic value of Microbot Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Microbot Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Microbot Medical helps investors to forecast how Microbot stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Microbot Medical more accurately as focusing exclusively on Microbot Medical's fundamentals will not take into account other important factors: Microbot Medical Total Value Analysis
Microbot Medical is currently anticipated to have takeover price of 25.72 M with market capitalization of 30.34 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Microbot Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
25.72 M | 30.34 M |
Microbot Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Microbot implies not a very effective usage of assets in November.Microbot Medical Profitability Analysis
Net Loss for the year was (11.31 M) with profit before overhead, payroll, taxes, and interest of 0.About Microbot Medical Valuation
The stock valuation mechanism determines Microbot Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Microbot Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Microbot Medical. We calculate exposure to Microbot Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Microbot Medical's related companies.8 Steps to conduct Microbot Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Microbot Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Microbot Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Microbot Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Microbot Medical's revenue streams: Identify Microbot Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Microbot Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Microbot Medical's growth potential: Evaluate Microbot Medical's management, business model, and growth potential.
- Determine Microbot Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Microbot Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.